At 14 weeks post Rps12 deletion, we began to observe mild pancytopenia (Figure 8E), a significant decrease in bone marrow cellularity, a decrease in HSC numbers, and a trend toward decreased progenitor populations (Figure 8F). Here, RPS12 is linked to Pancytopenia.